Kobe, Japan

Hiroshi Iwarkiri

This inventor holds 1 USPTO granted patent. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Iwarkiri: Innovator in Glycidyl Sulfonamide Compounds

Introduction

Hiroshi Iwarkiri is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of chemical engineering, particularly in the development of novel compounds that enhance material properties.

Latest Patents

Iwarkiri holds a patent for a glycidyl sulfonamide compound. This innovative compound features a (poly)siloxane main chain and is utilized either alone or in combination with an epoxy resin. The resulting cured material exhibits excellent flexibility, elongation, and impact strength, while maintaining thermal resistance, chemical resistance, and low water absorption. The patent also details a process for preparing this compound, which involves a condensation reaction with a sulfonyl chloride followed by an addition reaction with an epihalohydrin.

Career Highlights

Hiroshi Iwarkiri is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, where he has been instrumental in advancing research and development in polymer chemistry. His work has led to the creation of materials that are not only innovative but also practical for various applications.

Collaborations

Iwarkiri has collaborated with notable colleagues such as Yoshikuni Deguchi and Kazunari Iwamoto. Their combined expertise has contributed to the successful development of new materials and technologies.

Conclusion

Hiroshi Iwarkiri's contributions to the field of glycidyl sulfonamide compounds highlight his innovative spirit and dedication to advancing material science. His work continues to influence the industry and pave the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…